Top Biotechnology Startups in 2024

Synonym is a financing and development platform for essential biomanufacturing infrastructure - we’re building production capacity for synthetic biology companies and creating a new asset class for investors. We provide synbio companies with flexible capacity for microbial fermentation.  We build new biomanufacturing facilities, offering synbio companies access to dedicated, scalable capacity for minimal upfront capital investment. We accelerate project timelines and minimize internal complexity by handling facility development activities, from site selection through commissioning. We provide capital markets partners with curated access to biomanufacturing infrastructure investments, an emerging asset class and we manage these investments on behalf of investors, with an emphasis on risk management and maximizing returns.

Datavant protects, connects, and delivers the world’s health data to power better decisions and advance human health. Datavant is a data logistics company for healthcare whose products and solutions enable organizations to move and connect data securely. Datavant has a network of networks consisting of thousands of organizations, more than 70,000 hospitals and clinics, 70% of the 100 largest health systems, and an ecosystem of 500+ real-world data partners. Founded in 2017, we’ve doubled our team size and revenue every year. Our merger with Ciox Health, the leader in clinical data exchange, has made us the nation’s largest health data ecosystem with a $3.5B valuation. We are a remote-first team of ~1500 employees distributed across the US, Canada, and Europe.

Invitae is a leader in medical genetic testing, driving genetic information into mainstream medicine to improve healthcare for billions of people. Invitae is aggregating the world's medical genetic tests into a single service with higher quality, faster turnaround time, and lower prices. By driving down the cost of genetic testing we make it affordable and accessible to everyone who can benefit. Our dedication to our mission is fueling explosive growth, with both our test volume and revenue doubling year-over-year for the past four years. Our team has grown from 300 employees to more than 1,000 in just two years and we have helped hundreds of thousands of patients get the answers they need. Why medical genetics? Within each of us lies information coded in our DNA that can transform our health. Unlocking those answers to make medicine more personalized requires highly specialized, multidisciplinary collaboration. Our platform is setting the standard for the exploding medical genetics industry by harnessing the power of advanced technologies – robotics, artificial intelligence, machine learning, software engineering – and world-class genetic expertise. We provide genetic information that guides decisions for patients facing a vast array of health questions, from ultra-rare diseases and the most common cancers to starting a family. The team driving our mission thrives in a culture designed to enable innovation at scale. We are grounded in freedom with responsibility and a universal sense of urgency and ownership. Employees are empowered to speak up, try new things and make decisions that push us forward. We provide all employees with opportunities to grow and advance, supported by flexible work hours, unlimited paid time off, the ability to work anywhere for many roles and the satisfaction of doing meaningful work. Each day at Invitae means driving forward toward a new era in which everyone can have their health decisions guided by genetics.

Volta Labs was spun out of MIT in 2018 with the simple mission of building biological automation from the ground up. Volta is in the proximity of Kendall Square, known as "the most innovative square mile on the planet". Being part of the open biotech culture in Kendall Square made us realize that today’s biologists are held back by the limitations of existing automation tools. With DNA sequencing in particular, we observed that the advances in DNA readout technologies had moved further along than the advances in the upstream steps of preparing samples for sequencing (sample prep). ‍ What started out as a simple printed circuit board to manipulate colored droplets at the MIT Media Lab during co-founder Udayan Umapathi’s graduate work was quickly directed toward solving the “sample prep bottleneck”. The company raised Seed Funding from top VCs in 2019 and later that year added Will Langford as a co-founder and Head of Engineering. ‍ Since then, we have been heads down in the lab inventing and building novel fluidic and sample manipulation technologies. We take an anti-disciplinary approach to solve very hard problems and weave together instrumentation, fluidics, software, biology and chemistry. While our current focus is on sequencing sample prep, we envision a new approach where a single universal machine automates most biological workflows in genomics, proteomics and synthetic biology.

Mendel’s confounders are a physician and a computer scientist. Each dreamed of building a “Jarvis” for medicine since they were 15 years old. Mendel envisions a future where machines learn from all patients and power better decisions across the entire spectrum of healthcare.

Ultrahuman helps you improve your diet and exercise based on biomarkers. The metabolic health crisis is unarguably one of the largest healthcare crises that exists today. Metabolic disorders contribute to almost 85% of all chronic diseases in the world. By helping people understand how food and exercise affects their metabolic health, people would be able to make informed choices about what they eat and their activity levels.

Veeva builds enterprise cloud technology that powers the biggest names in the pharmaceutical, biotech, consumer goods, chemical & cosmetics industries. Our customers make vaccines, life-saving medicines, and life-enhancing products that make a difference in everyday lives. Our technology has transformed these industries; enabling them to get critical products and services to market faster. Our core values, Do the Right Thing, Customer Success, Employee Success, and Speed, guide us as we make our customers more efficient and effective in everything they do.

We have created a revolutionary silicon-based DNA synthesis platform, that offers precision at a scale otherwise unavailable to our customers. We provide an innovative silicon-based DNA Synthesis Platform which enables production of high-quality synthetic DNA which is faster and more affordable than ever before. Our platform allows you to work with genes, oligo pools (with CRISPR), variant libraries, DNA data storage and NGS target enrichment.

Shiru leverages machine learning and precision biology to identify and create ideal food proteins. at shiru we believe that food should be delicious and nourishing without negatively affecting our planet. acknowledging our growing global population as well as the imminent effects of climate change, shiru’s mission is to create better protein ingredients that will catapult us into a sustainable food future. with our mission in mind, shiru makes high quality, functional food proteins through better leveraging our precious environmental resources. to do this, we employ technologies originally created to solve problems in adjacent industries, including computational biology, machine learning, and industrial fermentation and bioprocessing.

Leapcure is a global team of thought leaders who elevate patient interactions to progress research for all. We do this with a purposeful, brave culture that deeply connects to each of our personal values. Through innovative technology and empathetic conversations, our impact is limitless.